None listed
Conditions
Interventions
None listed
Sponsors
Korea University Ansan Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adults aged 19 years or older and less than 80 years
Exclusion criteria
Exclusion criteria: 1) Subjects with known hypersensitivity or contraindications to any of the following drugs or materials: heparin, aspirin, clopidogrel, amphilimus, cobalt-chromium, stainless steel, nickel, 316L stainless steel, or contrast media. Subjects with contrast media hypersensitivity that can be adequately managed with steroids and antihistamines (e.g., pheniramine) may be enrolled; however, subjects with a known history of anaphylaxis are excluded. 2) Subjects who have a planned surgical procedure requiring discontinuation of antiplatelet therapy within 6 months after enrollment. 3) Women of childbearing potential who plan to become pregnant during the study period. 4)Subjects with a life expectancy of less than 1 year. 5)Subjects who are considered by the investigator to be unsuitable for participation in this study or at increased risk related to study participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite of stent-related cardiovascular events (cardiac death, myocardial infarction, and target lesion revascularization) | — |
Secondary
| Measure | Time frame |
|---|---|
| Composite of target vessel failure (cardiac death, myocardial infarction, and target vessel revascularization);Major adverse cardiac events (MACE), defined as a composite of death, target vessel-related myocardial infarction, or ischemia-driven target vessel revascularization;All-cause death;Cardiac death;Myocardial infarction;Stroke (ischemic or hemorrhagic);Stent thrombosis (definite or probable);Any revascularization;Bleeding events classified as BARC type 3 or higher | — |
Countries
Korea, Republic of
Contacts
Public ContactHyeYoung Heo
Korea University Ansan Hospital
Outcome results
None listed